Project description
Biomimetic mucus gel in the development of mucosal vaccine and restoration
Farmed fish is an important source of dietary proteins and nutrients. All fish surfaces are covered with a mucus layer, making it a model of choice for mucosal research. Mucins (MUC) are the glycoproteins of mucosal surfaces, providing lubrication and protection against pathogens. Chitosan (CS) is an amino polysaccharide studied for the treatment of MUC pathologies. The EU-funded cubiform project aims to evaluate a biomimetic mucus gel (BMG) for mucosal vaccination and restoration for farmed fish, and design CS-based nanodevices for loading in BMG applications. The objective is to characterise BMG effects on the metabolic, phagocytic activities, and the viability of immunocompetent cells for optimisation of an effective mucosal treatment.
Objective
This Project aims to evaluate a biomimetic mucus gel (BMG) for its use as mucosal vaccine and mucosal restoration for farmed fish. In addition, through a joint experimental and computational approach, rationalizing the design of chitosan (CS)-based nanodevices (ND) to load in BMG to apply on both healthy and disrupted mucosal surfaces. The aim of this project is to develop a treatment for improving animal health and welfare that are important goals in blue economy . The research work will be developed by the applicant, Dr. Collado González, in the group of Prof. María Ángeles Esteban (supervisor) at the University of Murcia (UM, host).
Farmed fish constitutes an essential way for providing dietary proteins and nutrients and they are used as a medical research model. In 2016 in EU, aquaculture resulted in about 75000 jobs and 1.3 million tonnes of aquatic animals which resulted in a gross value added of €2 billion in 2017. In fish, all surfaces are covered with mucus layer that is connected to the mucosal immunity. Mucins (MUC) are glycoproteins present at any mucosal surface . Among other functions, MUC increase lubricity of the mucosa and avoid infection by pathogens. CS refers to a family of aminopolysaccharides that have been proposed for the treatment of pathologies related to MUC. The characterization of the effects of the BMG on the metabolic and phagocytic activities as well as the viability of immune system cells will allow to optimize the BMGs to develop an effective mucosal treatment. A key issue in the development of applications in the field is that MUC and CS are families of flexible polymers with high variability in their properties and behaviour, reason why their interactions at the molecular level are difficult to unravel and not fully understood. Elucidating the main physicochemical forces behind such interactions will allow the optimization of transmucosal CS-based ND.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- agricultural sciences agriculture, forestry, and fisheries fisheries
- natural sciences chemical sciences polymer sciences
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs vaccines
- medical and health sciences basic medicine pathology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
30003 Murcia
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.